Disperse--a software system for design of selector probes for exon resequencing applications.

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

Who cites it

5 citing papers in PubMed.

1. New lung cancer panel for high-throughput targeted resequencing.Genomics & informatics · 2014
   Article
2. Diagnostics of primary immunodeficiency diseases: a sequencing capture approach.PloS one · 2014
   Article
3. Automated genotyping of biobank samples by multiplex amplification of insertion/deletion polymorphisms.PloS one · 2012
   Article
4. Targeted resequencing of candidate genes using selector probes.Nucleic acids research · 2011
   Article
5. A flexible approach for highly multiplexed candidate gene targeted resequencing.PloS one · 2011
   Article

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

Authors and funding

3 authors.

Funding

Abstract

Indexed as